Thus, restoring the expression of RBM3 that is suppressed in the bone microenvironment or modulating the m6A methylation of CTNNB1 may be important therapeutic approaches for inhibiting bone metastasis of PCa. This evidence concerns the gene CTNNB1 and posterior cortical atrophy.